Steve Mandel acquired 21M Medline shares worth $663M. That's 5.80% of their entire equity portfolio (6th largest holding). The investor owns 2.48% of the outstanding Medline stock. The investor's estimated purchase price is $874M, resulting in a loss of 24%.